Figure A1. Proportion of study participants with gram-negative bacteria resistant to antimicrobial agents, methicillin-resistant Staphylococcus aureus (MRSA), and methicillin-resistant, coagulase-negative staphylococci (MRCNS). For A and B, Acinetobacter baumanii and A. lwoffi were combined to represent Acinetobacter spp. For C and D, Enterobacter cloacae and E. agglomerans were combined to represent Enterobacter spp. IPM, imipenem; GEN, gentamicin; CIP, ciprofloxacin; AMK, amikacin; CAZ, ceftazidime; TIM, ticarcillin-clavulanic acid; SXT, trimethoprim-sulfamethoxazole; CRO, ceftriaxone; TZP, piperacillin-tazobactam.